OtherCommentary
A Biopharmaceutical Industry Perspective on the Control of Visible Particles in Biotechnology Derived Injectable Drug Products
Serge Mathonet, Hanns-Chistian Mahler, Stefan T. Esswein, Maryam Mazaheri, Patricia W. Cash, Klaus Wuchner, Goerg Kallmeyer, Tapan Das, Christof Finkler and Andrew Lennard
PDA Journal of Pharmaceutical Science and Technology April 2016, pdajpst.2015.006189; DOI: https://doi.org/10.5731/pdajpst.2015.006189
Serge Mathonet
1 Sanofi;
Hanns-Chistian Mahler
2 Lonza;
Stefan T. Esswein
3 Abbvie;
Maryam Mazaheri
4 medimmune;
Patricia W. Cash
4 medimmune;
Klaus Wuchner
5 Janssen R&D;
Goerg Kallmeyer
6 La Roche Ltd;
Tapan Das
7 Bristol Myers Squibb;
Christof Finkler
6 La Roche Ltd;
Andrew Lennard
8 Amgen
Article Information
pdajpst.2015.006189
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 27, 2015
- Accepted February 29, 2016
- Published online April 18, 2016.
Article Versions
- You are currently viewing a previous version of this article (April 18, 2016 - 18:05).
- View the most recent version of this article
Copyright & Usage
Copyright © 2016, Parenteral Drug Association
Author Information
- Serge Mathonet1,9 (serge.mathonet{at}sanofi.com),
- Hanns-Chistian Mahler2 (hanns-christian.mahler{at}lonza.com),
- Stefan T. Esswein3 (stefan.esswein{at}abbvie.com),
- Maryam Mazaheri4 (mazaherim{at}medimmune.com),
- Patricia W. Cash4 (cashp{at}medimmune.com),
- Klaus Wuchner5 (kwuchne1{at}its.jnj.com),
- Goerg Kallmeyer6 (georg.kallmeyer{at}roche.com),
- Tapan Das7 (tapan.das{at}bms.com),
- Christof Finkler6 (christof.finkler{at}roche.com) and
- Andrew Lennard8 (andrew.lennard{at}amgen.com)
- 1 Sanofi;
- 2 Lonza;
- 3 Abbvie;
- 4 medimmune;
- 5 Janssen R&D;
- 6 La Roche Ltd;
- 7 Bristol Myers Squibb;
- 8 Amgen
- ↵* Corresponding author; email: serge.mathonet{at}sanofi.com
Cited By...
This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.
- Wei Wang, Christopher J. RobertsInternational Journal of Pharmaceutics 2018 550 1-2
- Jinjiang Li, Mary E. Krause, Xiaodong Chen, Yuan Cheng, Weiguo Dai, John J. Hill, Min Huang, Susan Jordan, Daniel LaCasse, Linda Narhi, Evgenyi Shalaev, Ian C. Shieh, Justin C. Thomas, Raymond Tu, Songyan Zheng, Lily ZhuThe AAPS Journal 2019 21 3
- Eduard Trenkenschuh, Maximilian Richter, Eilien Heinrich, Marcus Koch, Gregor Fuhrmann, Wolfgang FriessAdvanced Healthcare Materials 2022 11 5
- Julia Gross-Rother, Michaela Blech, Eduard Preis, Udo Bakowsky, Patrick GaridelPharmaceutics 2020 12 11
- Ruta Mockute, Sameen Desai, Sujan Perera, Bruno Assuncao, Karolina Danysz, Niki Tetarenko, Darpan Gaddam, Danielle Abatemarco, Mark Widdowson, Sheryl Beauchamp, Salvatore Cicirello, Edward MinglePharmaceutical Medicine 2019 33 2
- Roman Mathaes, Linda Narhi, Andrea Hawe, Anja Matter, Karoline Bechtold-Peters, Sophia Kenrick, Sambit Kar, Olga Laskina, John Carpenter, Richard Cavicchi, Ellen Koepf, E. Neil Lewis, Rukman De Silva, Dean RippleThe AAPS Journal 2020 22 1
- Dominique Ditter, Alejandra Nieto, Hanns-Christian Mahler, Holger Roehl, Michael Wahl, Joerg Huwyler, Andrea AllmendingerJournal of Pharmaceutical Sciences 2018 107 2
- Maryam ShahInternational Journal of Pharmaceutics 2018 552 1-2
- Veronika Hampl, Xinghua Guo, Christian Ehrenstrasser, Martin Viertler, Lucy Rayner, Giusy Campanelli, Reinhard Schipflinger, Karine Thewes, Alessandra Cerreti, Stephan Boehm, Corinna SondereggerJournal of Pharmaceutical Sciences 2018 107 6
- Yihua Bruce Yu, Marc B. Taraban, Weizhen Wang, Katharine T. BriggsTrends in Biotechnology 2017 35 12
- Nidhi Doshi, Kyle Ritchie, Tamanna Shobha, Jamie Giddings, Kathrin Gregoritza, Rosalynn Taing, Stephen Rumbelow, Jeff Chu, Anthony Tomlinson, Aadithya Kannan, Miguel Saggu, Si Kai Cai, Victor Nicoulin, Wenqiang Liu, Steve Russell, Lin Luis, Sandeep YadavPharmaceutical Research 2021 38 9
- Rameez Kagdi, Kim Le, Dany Doucet, James Ludlow, Joseph V. RinellaJournal of Pharmaceutical Sciences 2020 109 11
- Vaida Linkuvienė, Emma L. Ross, Lindsey Crawford, Sarah E. Weiser, Damen Man, Stephen Kay, Parag Kolhe, John F. CarpenterJournal of Pharmaceutical Sciences 2022 111 4
- Margaret N. Ruesch, Luca Benetti, Eileen Berkay, David J. Cirelli, Neha Frantz, Martin H. Gastens, Wayne P. Kelley, Juliana Kretsinger, Mike Lewis, Shawn Novick, Barbara Rellahan, Laura Pack, Corné J.M. Stroop, Ann Subashi, Ping Yin, Ming Zeng, John StultsJournal of Pharmaceutical Sciences 2021 110 2
- Dhananjay Jere, Ahmad S. Sediq, Jörg Huwyler, Ilona Vollrath, Markus Kardorff, Hanns-Christian MahlerJournal of Pharmaceutical Sciences 2021 110 5
- Ema Valentina Brovč, Janez Mravljak, Roman Šink, Stane PajkEuropean Journal of Pharmaceutics and Biopharmaceutics 2020 154
- Tapan K. Das, Alavattam Sreedhara, James D. Colandene, Danny K. Chou, Vasco Filipe, Christoph Grapentin, Jim Searles, Twinkle R. Christian, Linda O. Narhi, Wim JiskootJournal of Pharmaceutical Sciences 2022 111 4
- Nidhi Doshi, Karen Rutherford, Asil NajjarJournal of Pharmaceutical Sciences 2021 110 2
- Maciej Stawny, Aleksandra Gostyńska, Malwina Nadolna, Anna JelińskaPharmaceutics 2020 12 3
- Kohei Soeda, Masakazu Fukuda, Masaya Takahashi, Hirotaka Imai, Kengo Arai, Satoshi Saitoh, Ravuri S.K. Kishore, Nuria Sancho Oltra, Jeremy Duboeuf, Daisuke Hashimoto, Yuji YamanakaJournal of Pharmaceutical Sciences 2022 111 8
- Katharine T. Briggs, Marc B. Taraban, Weizhen Wang, Y. Bruce YuAAPS PharmSciTech 2019 20 5
- Aadithya Kannan, Jamie Giddings, Shrenik Mehta, Tiffany Lin, Anthony Tomlinson, Kyle Ritchie, Ian Shieh, Miguel Saggu, Nidhi DoshiPharmaceutical Research 2022 39 3
- Rana Fayek, Mostafa Soleyman, Wim Jiskoot, Mirjam CrulEuropean Journal of Oncology Pharmacy 2021 4 3
- Srivalli N. Telikepalli, Michael J. Carrier, Dean C. Ripple, Greg Barnett, Ashwinkumar Bhirde, Donna Bolton, George M. Bou-Assaf, Erica Ferrari, Scott Leigh, Sophia Levitskaya-Seaman, Tim Menzen, Felix Nikels, Anna Riley, Miguel Saggu, Neha Sahni, Eric Vernooij, Klaus WuchnerAAPS PharmSciTech 2022 24 1
- Maryam Mazaheri, Miguel Saggu, Klaus Wuchner, Atanas V. Koulov, Felix Nikels, Pascal Chalus, Tapan K. Das, Patricia W. Cash, Christof Finkler, Sophia V. Levitskaya-Seaman, John Case, Jonny Parsons, Kristen GonzalezJournal of Pharmaceutical Sciences 2024 113 3
- Steven Messick, Miguel Saggu, Anacelia Ríos Quiroz2020 35
- Miguel Saggu, George M. Bou-Assaf, Reinhard Bucher, Ivan L. Budyak, Jakob Buecheler, Shawn Cao, Minna Groenning, Emon Khan, Stanley C. Kwok, Shalini Minocha, Karthik Pisupati, Vinay Radhakrishnan, Nicoline Videbæk, Dennis T. Yang, Bin Zhang, Linda O. NarhiJournal of Pharmaceutical Sciences 2024 113 5
- Mechanism of Protein–PDMS Visible Particles Formation in Liquid Vial Monoclonal Antibody FormulationKohei Soeda, Kengo Arai, Tetsuya Yamamoto, Katsuya Ofuji, Masakazu Fukuda, Daisuke Hashimoto, Yuji YamanakaJournal of Pharmaceutical Sciences 2023 112 3
- Ian Aled Jones, Alex Bird, Nathaniel LochrieEJPPS EUROPEAN JOURNAL OF PARENTERAL AND PHARMACEUTICAL SCIENCES 2021
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 78, Issue 2
March/April 2024
A Biopharmaceutical Industry Perspective on the Control of Visible Particles in Biotechnology Derived Injectable Drug Products
Serge Mathonet, Hanns-Chistian Mahler, Stefan T. Esswein, Maryam Mazaheri, Patricia W. Cash, Klaus Wuchner, Goerg Kallmeyer, Tapan Das, Christof Finkler, Andrew Lennard
PDA Journal of Pharmaceutical Science and Technology Apr 2016, pdajpst.2015.006189; DOI: 10.5731/pdajpst.2015.006189
A Biopharmaceutical Industry Perspective on the Control of Visible Particles in Biotechnology Derived Injectable Drug Products
Serge Mathonet, Hanns-Chistian Mahler, Stefan T. Esswein, Maryam Mazaheri, Patricia W. Cash, Klaus Wuchner, Goerg Kallmeyer, Tapan Das, Christof Finkler, Andrew Lennard
PDA Journal of Pharmaceutical Science and Technology Apr 2016, pdajpst.2015.006189; DOI: 10.5731/pdajpst.2015.006189
Jump to section
Related Articles
- No related articles found.
Cited By...
- Characterization of a Novel Particle in a Pharmaceutical Drug Product
- Development and Qualification of Visible Particle Load Analysis Methods for Injectable Drug Product Primary Packaging Components
- Micro-Flow Imaging: Estimation of the Contribution of Key Factors to the Variability of Subvisible Particle Count Measurement by a Nested Statistical Analysis
- Development of Protein-Like Reference Material for Semiquantitatively Monitoring Visible Proteinaceous Particles in Biopharmaceuticals
- Achieving "Zero" Defects for Visible Particles in Injectables
More in this TOC Section
Similar Articles
Keywords